ArticleBMC gastroenterology2022

CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia.

Athanasios Koulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.